Several previous studies also indicated DLBCL patients with mutations in some of these 41 genes, namely, MYC, ATM, BCL2, CREBBP, PIM1, and TP53 to be associated with poor survival [41,42]. Here, CREBBP is linked to diffuse large B-cell lymphoma.